Technical Analysis for MTZPY - Mitsubishi Tanabe Pharma Corporation

Grade Last Price % Change Price Change
grade B 11.52 -0.26% -0.0300
MTZPY closed down 0.26 percent on Thursday, October 17, 2019, on 39 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical MTZPY trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction -0.26%
NR7 Range Contraction -0.26%
Overbought Stochastic Strength -0.26%
Stochastic Reached Overbought Strength -1.29%
Overbought Stochastic Strength -1.29%
Bearish Engulfing Bearish 0.09%

Older signals for MTZPY ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mitsubishi Tanabe Pharma Corporation manufactures and sells pharmaceuticals in Japan, Europe, North America, other Asian countries, and internationally. The company offers drugs for autoimmune, diabetes, kidney, central nervous system, and other disease treatment; and vaccines, as well as sells generic drugs and over-the-counter (OTC) products. It offers Remicade for treatment of rheumatoid arthritis (RA), Crohn's, Bechet's, psoriasis, ankylosing spondylitis, and ulcerative colitis diseases; Simponi for the treatment of RA; Kremezin for the treatment of chronic renal failure; and Tenelia for type II diabetes mellitus. The company also provides Ceredist for the treatment of spinocerebellar degeneration; Depas, an anti-anxiety agent; Lexapro, an anti-depressant agent; Imusera for multiple sclerosis; Radicut, a cerebral neuroprotectant; Talion for the treatment of allergic disorders; Maintate for the treatment of hypertension, angina pectoris, ventricular extrasystole, chronic heart failure, and atrial fibrillation; Urso that improves hepatic, biliary, and digestive functions; and Anplag, an anti-platelet agent. In addition, it offers TETRABIK, a vaccine for diphtheria, pertussis, tetanus, and poliomyelitis; Varicella vaccine for the prevention of chicken pox; Influenza vaccine; Mearubik, a vaccine for measles and rubella; and JEBIK V for the prevention of Japanese encephalitis. Further, the company provides OTC products, including agents for the treatment of skin conditions; tonic and nutritional supplements; herbal and digestive medicines; and oral agents for allergic rhinitis and recurrent vaginal candidiasis. Additionally, it provides information about pharmaceuticals; and invests in bio-ventures. The company has collaborations with Dyadic International, Inc.; Hitachi Ltd.; and HitGen Ltd. The company was founded in 1678 and is headquartered in Osaka, Japan. The company is a subsidiary of Mitsubishi Chemical Holdings Corporation.
Medicine RTT Medical Specialties Pharmaceuticals Drugs Diabetes Pharmaceutical Industry In China Medication Disease Hypertension Multiple Sclerosis Psoriasis Rheumatoid Arthritis Influenza Vaccines Allergic Rhinitis Atrial Fibrillation Treatment Of Hypertension Angina Pectoris Chronic Heart Failure Janssen Biotech Measles Rhinitis Spondylitis Chronic Renal Failure Crohn's Japanese Encephalitis Remicade Rubella Tnf Inhibitors Varicella Allergic Disorders Chicken Pox Diphtheria Golimumab Ii Diabetes Mellitus Pertussis Poliomyelitis Prevention Of Chicken Pox Recurrent Vaginal Candidiasis Schering Plough Spinocerebellar Degeneration Tetanus Treatment Of Allergic Disorders Treatment Of Chronic Renal Failure Ulcerative Colitis Diseases Ventricular Extrasystole
Is MTZPY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 16.432
52 Week Low 10.59
Average Volume 40,988
200-Day Moving Average 12.5044
50-Day Moving Average 11.1709
20-Day Moving Average 11.288
10-Day Moving Average 11.2673
Average True Range 0.219
ADX 18.05
+DI 30.1165
-DI 22.9333
Chandelier Exit (Long, 3 ATRs ) 11.073
Chandelier Exit (Short, 3 ATRs ) 11.317
Upper Bollinger Band 11.8832
Lower Bollinger Band 10.6928
Percent B (%b) 0.69
BandWidth 10.545712
MACD Line 0.0696
MACD Signal Line 0.0193
MACD Histogram 0.0503
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.6100
Resistance 3 (R3) 11.6200 11.6000 11.5950
Resistance 2 (R2) 11.6000 11.5771 11.5950 11.5900
Resistance 1 (R1) 11.5600 11.5629 11.5500 11.5500 11.5850
Pivot Point 11.5400 11.5400 11.5350 11.5350 11.5400
Support 1 (S1) 11.5000 11.5171 11.4900 11.4900 11.4550
Support 2 (S2) 11.4800 11.5029 11.4750 11.4500
Support 3 (S3) 11.4400 11.4800 11.4450
Support 4 (S4) 11.4300